Company receives ISCT abstract award for the analytical characterization of its manufactured gamma-delta T cell therapies in ...

First gamma-delta (γδ) TCE to demonstrate significant γδ T cell expansion and activation, potentially offering an alternative to conventional CD3-based approaches without significant adverse ...

The 5th Gamma Delta T Cell Therapies Summit will bring together experts from big pharma, biotech and academia to delve into the details of gamma delta biology and its various subsets to offer the ...

A study using mice published in Science last month (March 19) may have unearthed a clue. The researchers show that poorly understood immune cells called gamma-delta T cells are responsible for ...

And of the Car-T cell treatments approved in the US since their debut in 2017, all target one of two markers found exclusively ... immune cells called gamma-delta T-cells could act as delivery ...

White blood cells in the GI tract known as intraepithelial lymphocytes express the gamma delta T cell receptor (gamma delta IELs), which prevent infection and provide surveillance for the ...

NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies for cancer and autoimmune ...

First gamma-delta (γδ) TCE to demonstrate significant γδ T cell expansion ... the expression of cellular markers indicating a transition to a powerful cancer-cell killing phenotype.

First gamma-delta (γδ) TCE to demonstrate significant γδ T cell expansion and activation, potentially offering an alternative to conventional CD3-based approaches without significant adverse ...

Targeted B cell elimination (INB-619) highlights potential applications in B cell–driven autoimmune diseases as well as cancer ...